Alzheimer'sLilly presents impressing results for Alzheimer’s drug donanemabLatest NewsEli Lilly’s Alzheimer’s drug donanemab has speedy removed amyloid plaques in a pivotal Phase III trail halting disease progression for one year in half of patients. Read more 19 July 2023 https://european-biotechnology.com/wp-content/uploads/2024/04/Eli_Lilly_and_Company_s_headquarters__c__Momoneymoproblemz_wikimedia_com.jpg 768 1024 Thomas Gabrielczyk /wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.png Thomas Gabrielczyk2023-07-19 13:35:312024-07-09 14:58:46Lilly presents impressing results for Alzheimer’s drug donanemab